Your session is about to expire
← Back to Search
Intraocular Lens
Nanoflex IOL for Bilateral NanoFlex Implantation
Phase 4
Waitlist Available
Research Sponsored by Innovative Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
The purpose of this study is to look at how well you see the Nanoflex Intraocular lens placed in your eye.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Uncorrected Near Visual Acuity
Trial Design
1Treatment groups
Active Control
Group I: Nanoflex IOLActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Innovative MedicalLead Sponsor
51 Previous Clinical Trials
2,528 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger